Latest News - The Aurum Institute

KAB study finds high COVID-19 awareness

As South Africa experiences a surge in the number of COVID-19 cases, the Aurum Institute has released findings of a research study on the knowledge, attitudes and behaviors which could be driving the ...
Smart Medication Container Included in GDF product Catalog

Stop TB Partnership’s Global Drug Facility (GDF) and the Unitaid-funded Adherence Support Coalition to End TB (ASCENT project) announce the inclusion of the first digital adherence technology (DAT) ...
Aurum staff participate in international HIV/AIDS awareness campaign

Staff from The Aurum institute’s Rustenburg Clinical Research Site, participated in an international campaign to mark National Black HIV/AIDS Awareness Day (NBHAAD). This is a US commemoration obse...
Aurum hosts first meeting as SAHTAC secretariat

The Aurum Institute recently hosted the annual general meeting of the South African Health Technologies Advocacy Coalition (SAHTAC), the first since it took over the secretariat role this year. Spea...
Eaton shines a light on Aurum

A generous donation of electricity generating equipment from Eaton Africa, will help Aurum continue to provide public health services during power cuts. The energy management company handed over UPS...
Prevention has to be a priority for all diseases, not just the pandemic of the moment

...
World TB Day- TB treatments are notoriously hard to stick to: shorter regimens offer a breakthrough

This article by Prof Violet Chihota, was originally published in The Conversation Tuberculosis (TB) is a major cause of illness and death around the world. In 2019, 10 million people fell ill with...
High risk of Tuberculosis in people living with HIV

The Lancet Global Health journal reports the findings of a study of a host blood test that can find those at high risk of tuberculosis in people living with HIV. The blood mRNA biomarker differentiate...
After setbacks, rollout of new TB prevention pills to start in six districts

This article was originally written by Tiyese Jeranji for Spotlight on 14th April 2021. After various delays and setbacks, new, less toxic, short-course tuberculosis (TB) prevention therapy is fi...
Aurum staff appointed to Vanderbilt University

The Aurum Institute is proud to announce that 10 senior staff members have been appointed in various adjunct positions at the Department of Medicine in the Vanderbilt University School of Medicine. T...
Improving availability of patient-friendly tuberculosis preventive therapy

Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy...
As'bangene campaign speaks to young people in their language

The Aurum Institute’s AS’BANGENE movement has been ‘doing the most’ since its launch in March, using engaging campaigns to reach young people to encourage and support them to make healthy life...
Innova CEO takes COVID-19 vaccinations to his home province

Bandile Mathandela, CEO of Aurum Innova says there is a sense of pride in bringing lifesaving COVID-19 vaccinations to the people of the Eastern Cape, not only because it is his home province, but als...
IMPAACT4TB Project statement responding to the WHO Global TB Report 2021

IMPAACT4TB Welcomes Gains in TB Prevention Among People Living With HIV, But Calls for Urgent Action to Address TB Prevention Deficits Among Children and Household Contacts of People Affected by TB ...
Q&A: Locally led leadership key to global health solutions

This article was originally published in Devex on 15 November 2021 It’s time for low-income countries on the African continent and elsewhere to stand up and take on leadership in finding globa...
Aurum welcomes new board members

The Aurum Institute welcomes three new members to its Board of Directors, each bringing a wealth of expertise. Dr Jerry Gule, Yaw Peprah and Paula Fray recently joined the Aurum Board as non-executi...
Aurum at 21st ICASA

Aurum was at the 21st International Conference on AIDS and Sexually Transmitted Infections (STIs) in Africa (ICASA). This year themed; The race to 2030 – Evidence. Scale Up. Accelerate, the conferen...
Aurum at Forum on Microbial Threats workshop

Aurum Group CEO Prof Gavin Churchyard presented at the Forum on Microbial Threats workshop recently. The Forum which is part of the National Academies of Sciences, Engineering, and Medicine, brought...
As’bangane: Linking clients to Aurum’s services

Sibusiso Nkabinde has been diligently taking his antiretroviral treatment (ART) for 7 years, but with the advent of COVID-19, he found himself conflicted. “From the very beginning there were concer...
IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program

Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity NEW YORK, NY AND CAMBRIDGE, MA — MAY 18,...